Neuroscience

Setting the odds for those with MS

Both the doctors who treat multiple sclerosis and the people who experience it agree that the disease is highly unpredictable.

Medical research

Research pinpoints powerful biomarker of multiple sclerosis

A breakthrough study led by the University of Sydney's Brain and Mind Centre and Royal Prince Alfred Hospital has revealed unique molecules in the blood of people with Multiple Sclerosis (MS) that could become definitive ...

Diseases, Conditions, Syndromes

Siponimod cuts risk of disability progression in multiple sclerosis

(HealthDay)—For patients with secondary progressive multiple sclerosis, the selective sphingosine 1-phosphate (S1P) receptor1,5 modulator, siponimod, is associated with reduced relative risk of confirmed disability progression, ...

Neuroscience

Researchers define two categories of multiple sclerosis patients

There are approximately 400,000 people in the United States with multiple sclerosis. Worldwide, the number jumps to more than 2.1 million people. Rather than a one-size-fits-all approach to treating the millions with multiple ...

page 37 from 40